共 190 条
[1]
Davies C G(2011)Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 771-784
[2]
Godwin J(2011)Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen Breast Cancer Res Treat 126 421-430
[3]
Gray R(2006)High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients Clin Cancer Res 12 4614-4618
[4]
Clarke M(2007)Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer Acta Oncol 46 133-145
[5]
Cutter D(1978)Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel Anal Biochem 85 461-475
[6]
Darby S(2000)A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data Stat Med 19 2595-2609
[7]
McGale P(2004)A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials Stat Med 23 2509-2525
[8]
Pan HC(2006)REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229-235
[9]
Taylor C(2013)Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype Breast Cancer Res 15 R68-76
[10]
Wang YC(2000)Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group Breast Cancer Res Treat 59 69-1979